Eight hundred seventy patients with metastatic nonseminomatous germ cell cancer underwent postchemotherapy retroperitoneal lymph node dissection (PC- RPLND) for resection of residual disease. Several risk factors for relapse and survival were identified as highly significant (P = .00001), namely, presence of residual cancer in the specimen before salvage chemotherapy programs, tumor marker elevation, need for 're-do' PC-RPLND, or unresectability. Although more than half of the entire group (52.5%) had one or more of these risk factors, 67.5% are long-term survivors following PC- RPLND. The remaining 47.5% were referred after primary chemotherapy, without risk factors. Only 9.8% relapsed end 95.5% survived.
|Original language||English (US)|
|Number of pages||7|
|Journal||Seminars in Urologic Oncology|
|State||Published - Jun 22 1998|
ASJC Scopus subject areas